97149 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
ANTIBODY, RELATED USE, PHARMACEUTICAL COMPOSITION INCLUDING METHOD FOR DIAGNOSING FUNGAL INFECTIONS, FUNGAL INFECTION DIAGNOSIS KIT AND METHOD FOR TREATING FUNGAL INFECTIONS
#2CRISPR-BASED MODULAR TOOL FOR THE SPECIFIC INTRODUCTION OF EPIGENETIC MODIFICATIONS AT TARGET LOCI
#3THERAPEUTIC AGENT COMPRISING MULTISPECIFIC ANTIBODY AND USE THEREOF IN TUMOR THERAPY
#4VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE
#5MODIFIED STRAINS FOR IMPROVED SECRETION OF RECOMBINANT PROTEINS
#6ANTIBODY MOLECULES AND USES THEREOF
#7METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS
#8ANTI-FUNGAL VHH ANTIBODIES
#9LATERAL FLOW ASSAY FOR THE DIAGNOSIS OF DERMATOMYCOSIS
#10OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS
#11ANTIBODIES AND METHODS FOR GENERATING THE SAME
#12Magnetic chemiluminescence immunoassay kit based on bifunctional fusion protein for mycotoxins, and use thereof
#13METHODS OF ISOLATING ALLERGEN-SPECIFIC ANTIBODIES FROM HUMANS AND USES THEREOF
#14POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE
#15COMPOSITIONS AND METHODS FOR NEUTRALIZING ANTIGENS
#16ANTIBODIES AGAINST CANDIDA ALBICANS PROTEINS AND THEIR THERAPEUTIC AND PROPHYLACTIC USE FOR TREATING AND PREVENTING INVASIVE FUNGAL INFECTIONS
#17METHODS FOR CONTROLLING PROTEASE PRODUCTION
#18ANTIBODY, RELATED USE, PHARMACEUTICAL COMPOSITION INCLUDING METHOD FOR DIAGNOSING FUNGAL INFECTIONS, FUNGAL INFECTION DIAGNOSIS KIT AND METHOD FOR TREATING FUNGAL INFECTIONS
#19METHODS OF IMMUNOTHERAPY
#20UNIVERSAL RETARGETING OF ONCOLYTIC HSV
#21COTH3 BINDING AGENTS AND USES THEREOF
#22ANTIBODIES TARGETING TALAROMYCES MARNEFFEI MP1P PROTEIN AND METHODS OF USE THEREOF
#23METHOD AND KIT FOR DETECTION THE PRESENCE OF SILVER LEAF DISEASE CHONDROSTEREUM PURPUREUM FUNGUS
#24AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY TARGETING CANDIDA
#25Modified strains for improved secretion of recombinant proteins
#26HUMANISED ANTIBODIES AGAINST PATHOGENIC FUNGI
#27Fungal (1,3)-Beta-D glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof
#28MONOCLONAL ANTIBODIES DIRECTED TO PEPTIDE IN THE CONTEXT OF MHC AND METHODS OF MAKING AND USING MONOCLONAL ANTIBODIES
#29Anti-fungal polypeptides
#30TRANSGENIC PLANTS EXPRESSING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY (VHH) THAT BINDS TO A SPHINGOLIPID OF A FUNGUS
#31ANTI-FUNGAL POLYPEPTIDES
#32CAR T CELLS THAT TARGET ASPERGILLUS-ASSOCIATED ANTIGENS
#33TREATMENT AND PROTECTION AGAINST ASPERGILLUS INFECTION AND ASPERGILLOSIS DISEASE
#34ANTIBODIES TO CANDIDA AND USES THEREOF
#35Antibody molecules and uses thereof
#36PATHOGEN BINDING METHODS AND COMPOSITIONS
#37TREATMENT AND DETECTION OF INFECTION AND DISEASE ASSOCIATED WITH DIFFERENT FUNGAL PATHOGENS
#38COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES
#39ANTIBODY MOLECULES AND USES THEREOF
#40Method for co-diagnosis of ralstonia solanacearum and fusarium oxysporum by using semi-quantitative lateral flow immunodiagnostic technique and kit for use therein
#41Aspergillus antigen chimeric receptors and use thereof
#42METHODS FOR IDENTIFYING BETA-GLUCAN BINDING TO IMMUNE CELLS
#43Anti-galactofuranose antibodies for detecting and treating aspergillosis
#44Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
#45Antibody mimetic capable of being activated reversibly and uses thereof
#46OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS
#47Reduction of viral disease transmission by avian antibodies
#48TRANSGENIC PLANT COMPRISING A POLYNUCLEOTIDE ENCODING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY
#49Allergen-specific antibodies
#50Identifying human B cells expressing anti-allergen antibodies
#51Antibodies Targeted to Fungal Cell Wall Polysaccharides
#52Anti-galactofuranose antibodies for detecting and treating aspergillosis
#53AGROCHEMICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO SPHINGOLIPIDS
#54Methods of isolating allergen-specific antibodies from humans and uses thereof
#55NOVEL FUNGAL TOXINS AND METHODS RELATED TO THE SAME
#56Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#57BREVETOXIN ASSAY DEVICE, SYSTEM, AND METHOD
#58NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF
#59Methods for controlling protease production
#60Antibodies against infectious diseases
#61METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS
#62C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES
#63High affinity monoclonal antibodies for detecting amanitins
#64Antibodies targeted to fungal cell wall polysaccharides
#65Methods, compositions, and kits for detection of aspergillosis
#66Optimizing diagnostics for galactofuranose containing antigens
#67Fungal Detection Using Mannan Epitope
#68Treatment and detection of infection and disease associated with different fungal pathogens
#69Human IgE antibodies binding to aspergillus allergens
#70Antibodies targeted to fungal cell wall polysaccharides
#71Antibody
#72SEC modified strains for improved secretion of recombinant proteins
#73Agrochemical compositions comprising antibodies binding to sphingolipids
#74NANOBODY VAGINAL ADMINISTRATION SYSTEM AND PREPARATION METHOD AND USE THEREOF
#75BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING
#76Fc mutants with improved functional activity
#77Methods for diagnosis of infection and selection of plant resistance genes to the same
#78Fungal toxins and methods related to the same
#79Use of immobilization particles for removal of microorganisms and/or chemicals
#80Switchable antibody conjugate
#81IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING COTH
#82Antibodies targeted to fungal cell wall polysaccharides
#83Antibody mimetic capable of being activated reversibly and uses thereof
#84BETA-GLUCAN ASSAY METHODS
#85GM hybridoma cell, monoclonal antibody, kit and preparation method and use thereof
#86COMPOSITIONS AND METHODS FOR TREATING FUNGAL AND BACTERIAL PATHOGENS
#87Method of treating fungal infection
#88COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY
#89Method employing bispecific protein complex
#90Method employing bispecific antibodies
#91Multispecific antibodies
#92Multispecific antibodies
#93Multispecific antibodies
#94Aptamers for mycotoxin detoxification
#95Antibodies against infectious diseases
#96IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
#97Monoclonal antibodies directed to peptide in the context of MHC and methods of making and using monoclonal antibodies
#98Antibodies targeted to fungal cell wall polysaccharides
#99TRANSGENIC PLANT COMPRISING A POLYNUCLEOTIDE ENCODING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY
#100PEPTIDES AND BINDING PARTNERS THEREFOR
#101Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus
#102Optimizing diagnostics for galactofuranose containing antigens
#103PCA1 PROTEIN AND METHODS OF TREATING PNEUMOCYSTIS PNEUMONIA INFECTION
#104Fungal detection using mannan epitope
#105ANTI-GLYCOPROTEIN ANTIBODIES AND USES THEREOF
#106Beta-glucan assay methods
#107Methods for detecting and treating fungal infections
#108NOVEL AFLATOXIN AND FUNGAL INFECTION CONTROL METHODS
#109CalA BINDING AGENTS, CalA PEPTIDES AND METHODS OF USE
#110Methods for controlling protease production
#111Antibody molecules and uses thereof
#112Agrochemical compositions comprising antibodies binding to sphingolipids
#113Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#114A PROTEIN TAGGING SYSTEM FOR IN VIVO SINGLE MOLECULE IMAGING AND CONTROL OF GENE TRANSCRIPTION
#115PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS
#116Chimeric vaccine against fungal infections
#117Bispecific format suitable for use in high-through-put screening
#118Antibody preparations
#119Methods, compositions, and kits for detection of aspergillosis
#120Histamine releaser contained in human sweat
#121Aflatoxin nanobody immunoabsorbent and immunoaffinity column and preparation method and use thereof
#122β-glucan assay methods
#123THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR BEE COLONY COLLAPSE SYNDROME
#124Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
#125Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
#126CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#127IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING COTH
#128AGROCHEMICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO SPHINGOLIPIDS
#129Use of immobilization particles for removal of microorganisms and/or chemicals
#130Agrochemical compositions comprising antibodies binding to sphingolipids
#131Peptides and binding partners therefor
#132Compositions and methods for treating fungal and bacterial pathogens
#133COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS
#134ANTIBODIES TARGETED TO FUNGAL CELL WALL POLYSACCHARIDES
#135Aflatoxin M1 nanobody 2014AFM-G2
#136Hybridoma cell line ST03, monoclonal antibody against aflatoxin biosynthetic precursor sterigmatocystin and use thereof
#137Histamine releaser contained in human sweat
#138Monoclonal IgE antibody that binds to sweat allergy antigen protein
#139Lateral flow device for diagnosing microbial infections
#140HYR1-derived compositions and methods of treatment using same
#141Methods for identifying beta-glucan binding to immune cells
#142Compositions and methods for beta-glucan immunotherapy
#143MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF
#144Antibody preparations
#145Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
#146Treatment of mucositis with immunoglobulin
#147ANTIBODY
#148Endogenous regulator of RNA silencing in plants
#149Antibody specific for trans-resveratrol and use thereof
#150Methods, compositions, and kits for detection of aspergillosis
#151Method of treating fungal infection
#152Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
#153METHODS AND COMPOSITION FOR TESTING, PREVENTING, AND TREATING ASPERGILLUS FUMIGATUS INFECTION
#154Synthetic antibodies
#155Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof
#156Pharmaceutical compositions and methods to vaccinate against candidiasis
#157PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS
#158PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS
#159POLYCLONAL ANTIBODIES TO CLONED FUNGAL POLYPEPTIDE TARGETS
#160Mammalian receptors as targets for antibody and active vaccination therapy against mold infections
#161Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#162Hybridoma cell line 10G4 and a monoclonal antibody against the total of aflatoxin B1, B2, G1 and G2
#163Peptide and conjugate vaccines for fungal infections
#164Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
#165Chitinous polysaccharide antigen-binding proteins
#166Compositions for seed treatment
#167Endophyte enhanced seedlings with increased pest tolerance
#168NOVEL PROTEIN AND USE THEREOF
#169Immunotherapy and diagnosis of mucormycosis using CotH
#170Process for preparing an immunoglobulin composition
#171Antibody preparations
#172Lateral flow device for diagnosing microbial infections
#173SINGLE CHAIN ANTIBODIES FOR PHOTOSYNTHETIC MICROORGANISMS AND METHODS OF USE
#174COMPOSITIONS AND METHODS FOR TREATING ASPERGILLOSIS
#175Therapeutic using a bispecific antibody
#176ANTI-PSK ANTIBODY
#177Immobilization Particles for Removal of Microorganisms and/or Chemicals
#178Protective anti-glucan antibodies with preference for β-1,3-glucans
#179VACCINE COMPOSITIONS AND METHODS FOR TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES
#180ANTIBODY
#181Antibody fusion-mediated plant resistance against Oomycota
#182Streptavidin having low immunogenicity and use thereof
#183PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
#184YEAST CELL WALL COMPONENTS AND DETECTION THEREOF
#185Recombinant antibodies to antigens
#186Antibodies against candida, collections thereof and methods of use
#187Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
#188Endophyte enhanced seedlings with increased pest tolerance
#189Synthetic Antibodies
#190Glucan-based vaccines
#191MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS
#192Hapten, Immunogens and Derivatives of Ascomycin Useful for Preparation of Antibodies and Immunoassays
#193USE OF HEAT-RESISTANT BIOTIN-BINDING PROTEIN, AND SOLID SUPPORT HAVING THE PROTEIN ATTACHED THERETO
#194Protective anti-glucan antibodies with preference for β-1,3-glucans
#195Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
#196Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
#197Antibodies against delta-5 desaturase and uses thereof
#198Monoclonal antibody specific to ochratoxin A
#199LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
#200NOVEL ANTIBODY MOLECULES AND NUCLEIC ACIDS
#201NOVEL ANTIBODY MOLECULES AND NUCLEIC ACIDS BINDING TO FUNGAL STRESS PROTEIN HSP90
#202Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins
#203THERAPEUTIC COMPOSITION COMPRISING AN INHIBITOR OF AN HSP 90 PROTEIN
#204Endogenous regulator of RNA silencing in plants
#205PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
#206Modulators of hyphal morphogenesis and uses thereof
#207Protective anti-glucan antibodies with preference for β-1,3- glucans
#208Composition
#209Antibody molecules and nucleic acids
#210Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
#211THERAPEUTIC ALKALINE PROTEASE COMPOSITIONS AND USE IN FACILITATING THE TRANSPORT OF AGENTS ACROSS THE GASTROINTESTINAL MUCOSAL LINING
#212Intrabodies with defined framework that is stable in a reducing environment and applications thereof
#213Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
#214Antibodies against antigens
#215Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
#216Recombinant antibodies to sclerotinia antigens
#217Treatment of fungal infections
#218Antigenic protein originating in
#219Glycosylated polypeptides produced in yeast mutants and methods of use thereof
#220Antifungal Peptides
#221Therapeutic using a bispecific antibody
#222Therapeutic composition
#223Glucan-based vaccines
#224Antibodies to the propeptide of candida albicans and methods of use
#225Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
#226Light harvesting optical, optoelectronic, and photovoltaic devices
#227Extracellular aspergillus polypeptides
#228Systems for isolating toxins and collecting eluates for testing for toxins and methods using the same
#229Sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins
#230Method of promoting an immune response with a bispecific antibody
#231Rapamycin conjugates and antibodies
#232Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
#233Antibodies reactive with beta (1-3)-glucans
#234Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions
#235Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
#236Colostrum-based composition
#237Glucan-based vaccines
#238Polyclonal antibody composition for treating allergy
#239Hapten, immunogens and derivatives of ascomycin useful for preparation of antibodies and immunoassays
#240Sandwich immunoassay kits for detecting ciguatoxin CTX3C